Dermatology


Defining The Unique Skin And Blood Biomarkers Of Pediatric Atopic Dermatitis
Principal Investigator: Amy Paller, MD
Contact: Gil Abramovici, MD
Phone:
312.227.6484
E-mail:
GAbramovici@luriechildrens.org
 ClinicalTrials.gov Identifier  NCT01782703; IRB Number: 2003-15143
 ***As featured on WGN TV Chicago
 


Effect of Acne Vulgaris on the Quality of Life of Teenagers Compared to Parents Perceived Effect on Quality of Life
Principal Investigator:  Jennifer Sorrell, MD
Contact:  Lauren Becker, MD
Phone:  312.227.6485
Email: 
LRBecker@luriechildrens.org
IRB Number 2012-15072 


Atopic Dermatitis Research Network Registry 
Principal Investigator:  Amy Paller, MD
Contact:  Victoria Godinez-Puig, MD
Phone: 312.695-6786
Email:
Victoria.godinez-puig@northwestern.edu
ClinicalTrials.gov Identifier: NCT01494142; IRB Number  2011-14678 


Open-label, Pilot study to Investigate the Safety and Tolerability of Alwextin 3.0% Cream in the Treatment of Epidermolysis Bullosa 
Principal Investigator:
Amy Paller, MD
Contact: Benjamin Bohaty, MD
Phone: 312.227.6486 
E-mail: 
  benjamin.bohaty@northwestern.edu

ClinicalTrial.gov Identifier:  NCT00825565; IRB Number 2009-13625
  


Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy (HEMANGIOL)
Principal Investigator:Anthony J. Mancini, MD
Contact: Lauren R Becker, MD
Phone: 312.227.6485
E-mail:
AMancini@northwestern.edu;   LRBecker @luriechildrens.org
ClinicalTrials.gov Identifier:  NCT01056341; IRB Number 2010  


ADVN Biomarker Registry Study  
Principal Investigator:
Amy Paller, MD 
Contact:  Victoria Godinez-Puig, MD
Phone: 312.695-6786
Email:
Victoria.godinez-puig@northwestern.edu 
ClinicalTrials.gov identifier: NCT00550316;  IRB Number: 2008-13500/13508    


Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis (Genetics)
Principal Investigator:
 Amy Paller, MD 
Contact: Benjamin Bohaty. MD
Phone: 312.227.6486
Email: 
 benjamin.bohaty@northwestern.edu 
ClinicalTrials.gov identifier: NCT00515047  
An Open-label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects with Plaque Psoriasis
Principal Investigator: Amy Paller, MD

Contact: Benjamin Bohaty. MD
Phone: 312.227.6486
Email:  
benjamin.bohaty@northwestern.edu 

ClinicalTrials.gov Identifier: NCT00141921  (IRB Number: 2005-12643)

Genetic Screening for Dermatologic Diseases
Principal Investigator: Amy Paller, MD

Contact: Benjamin Bohaty. MD
Phone: 312.227.6486
Email:  
benjamin.bohaty@northwestern.edu 

IRB Number:
2009-13803   
 


APPLES:  A Prospective Pediatric Longitudinal Evaluation to Assess the Long-term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis.  
Principal Investigator: Amy Paller, MD

Contact Person: Lauren R Becker, MD

Email: 
  LRBecker@luriechildrens.org 
Phone number: 312.227.6485

ClinicalTrials.gov Identifier: NCT00475605 (IRB Number: 2005-12622)
   
 


Defining the Unique Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
Principal Investigator: Amy Paller, MD
Contact: Lauren Becker, MD
Phone: 312.227.6485
Email:
LRBecker@luriechildrens.org
ClinicalTrials.gov Identifier NCT01782703 (IRB 2013-15134)    


Study of the Efficacy and Safety of ABH001 for the Treatment of Patients with Epidermolysis Bullosa Who Have Wounds that Are Not Healing
Principal Investigator: Amy Paller, MD
Contact: Lauren Becker, MD
Phone: 312.227.6485
Email:
LRBecker@luriechildrens.org
ClinicalTrials.gov Identifier: NCT01749306 (IRB 2013-15197)  


Epidermolysis Bullosa Clinical Characterization and Outcomes Database
Principal Investigator: Amy Paller, MD
Contact: Lauren Becker, MD
Phone: 312.227.6485
Email:
LRBecker@luriechildrens.org
(IRB 2011-14549
 


Systemic Therapies for Pediatric Atopic Dermatitis
Principal Investigator: Amy Paller, MD
Contact: Benjamin Bohaty, MD
Phone: 312.227.6486
Email:
benjamin.bohaty@northwestern.edu
ClinicalTrials.gov Identifier: NCT01447381 (IRB 2011-14488) 
 
 


A Study to Evaluate CLn® BodyWash as Added Therapy in Eczema Patients (CLeaN)
Principal Investigator: Amy Paller, MD
Contact: Benjamin Bohaty, MD
Phone: 312.227.6486
Email: benjamin.bohaty@northwestern.edu ClinicalTrials.gov Identifier: NCT01714245 (IRB 2013-15198) 
  


Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005%, Applied Under Maximal Use Conditions in Adolescent Subjects (Ages 12 to 16 Years) with Plaque Psoriasis.
Principal Investigator: Amy Paller, MD
Contact: Benjamin Bohaty, MD
Phone: 312.227.6486
Email: benjamin.bohaty@northwestern.edu
ClinicalTrials.gov Identifier: NCT01563068 (IRB 2013-15296) 
 

 Childhood Atopic Dermatitis Impact Scale (CADIS)  

Principal Investigator: Amy Paller, MD Contact: Lauren Becker, MD Phone: 312.227.6485 Email: (IRB 2011-14549)    Principal Investigator: Amy Paller, MD Contact: Benjamin Bohaty, MD Phone: 312.227.6486 Email: benjamin.bohaty@northwestern.edu ClinicalTrials.gov Identifier: NCT01714245 (IRB 2013-15198)     Principal Investigator: Amy Paller, MD Contact: Benjamin Bohaty, MD Phone: 312.227.6486 Email: benjamin.bohaty@northwestern.edu ClinicalTrials.gov Identifier: NCT01714245 (IRB 2013-15198)